• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Medical Device Testing Services Market Analysis

    ID: MRFR/MED/10831-HCR
    131 Pages
    Rahul Gotadki
    October 2025

    Medical Device Testing Services Market Research Report Information By Services (Biocompatibility Tests, Chemistry Test and Microbiology & Sterility Test), By Phase (Preclinical and Clinical) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World), Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Medical Device Testing Services Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Analysis

    Medical Device Testing Services (Global, 2025)

    Introduction

    In an increasingly complex health system, the Medical Device Testing Services market is destined to play a critical role in ensuring the safety, efficacy, and regulatory compliance of medical devices. As medical technology continues to evolve at an unprecedented pace, the demand for comprehensive testing services has grown at an even faster pace, driven by the need for a rigorous evaluation process that meets the most stringent regulatory requirements. Testing services include biocompatibility testing, performance testing, and clinical evaluation, all of which are essential to manufacturers who wish to successfully bring new products to market. A greater emphasis on patient safety and a growing number of medical device recalls have also increased the importance of reliable testing services. The Medical Device Testing Services market is expected to continue to evolve as a result of emerging technology, regulatory changes, and the increasing globalization of the supply chain.

    PESTLE Analysis

    Political
    In 2025, the regulatory framework for medical device testing services will be influenced by government policies that aim to ensure patient safety and product efficacy. The US Food and Drug Administration (FDA) has implemented new guidelines that will require all medical devices to undergo stringent testing procedures, which will result in an estimated 30% increase in premarket submissions compared to 2024. The European Union’s Medical Device Regulation (MDR) stipulates that all devices must be tested by an authorized body, which will result in a projected 15% increase in the number of authorized testing facilities in Europe.
    Economic
    In 2025, the economic environment for medical device testing services is characterized by increased investment in health innovation. By then, global expenditure on health care is estimated to reach around $ 10 trillion, of which a significant share will be spent on medical device development and testing. The average cost of clinical trials for medical devices is estimated to reach $ 2 million, which reflects the increasing complexity and regulatory requirements of testing new products. This economic environment will support the demand for specialized testing services.
    Social
    In 2025, social factors influencing the medical device testing services market will include a growing public awareness of health and safety standards. In a survey, 78% of consumers said they trust medical devices that have undergone rigorous testing and certification processes. The aging population, which is projected to reach 1.5 billion in 2025, will increase the demand for medical devices, thereby increasing the need for comprehensive testing to ensure their safety and effectiveness.
    Technological
    In 2025, the medical device testing market will be transformed by the introduction of artificial intelligence (AI) and machine learning (ML) in the testing process. It is estimated that 40% of the testing processes will be using ML-driven analytics to increase accuracy and efficiency. Virtual reality (VR) is also gaining traction in the testing industry, and it is estimated that by 2025, at least 25% of the testing centers will have adopted this technology. The virtual reality-based testing will help reduce the time and cost of testing for complex devices.
    Legal
    In 2025 the regulations governing the testing of medical devices are getting more and more stringent. The new law requires all testing laboratories to conform to ISO 13485, the international standard for quality management of medical devices. In 2025 about 85% of the testing laboratories are expected to be certified to this standard, which ensures compliance with international regulations. A new law introducing higher fines for non-compliance, up to $500,000 for a single offence, is putting the compliance of companies at the top of their priorities.
    Environmental
    In the field of medical device testing, the emphasis on the environment is growing, and the emphasis on sustainable development is growing. Green Deal in the European Union is expected to lead to a reduction in the medical device industry of 20 percent in the production and testing of medical devices. In addition, it is expected that 60 percent of testing laboratories will adopt eco-friendly practices such as reducing waste and using energy-efficient technology in response to increasing regulatory pressure and growing demand for sustainable products.

    Porter's Five Forces

    Threat of New Entrants
    The medical device testing services market has a medium barrier to entry due to the need for specialized knowledge, regulatory compliance and a large capital investment. The presence of well-established players with strong reputations and established relationships with manufacturers makes it difficult for new entrants to enter the market. However, technological advancements and the growing demand for testing services are likely to encourage new companies to enter the market.
    Bargaining Power of Suppliers
    The bargaining power of the suppliers in the market for medical device testing services is generally low. There are a large number of suppliers in the market, who offer various types of testing equipment and materials. These suppliers are numerous enough to allow the testing service providers to easily switch between them, which reduces the power of each supplier to influence the price and terms of the transaction.
    Bargaining Power of Buyers
    High - Medical device manufacturers have high bargaining power in this market because of the availability of several testing service providers. They can therefore demand favorable terms and prices as a result of their need to ensure regulatory compliance. Furthermore, the increasing focus on quality and safety of medical devices gives buyers the power to demand high standards and competitive prices.
    Threat of Substitutes
    The threat of substitutes in the medical device testing market is moderate. There are some substitutes to third-party testing, such as in-house testing, but they lack the credibility and regulatory compliance of third-party testing. However, technological developments may lead to new testing methods that may be substitutes in the future.
    Competitive Rivalry
    Competition in the medical device testing services market is high, driven by the presence of numerous established players and the constant demand for new testing solutions. Competition is based on factors such as quality, speed, and cost-effectiveness. The rapid technological development and regulatory changes are intensifying the competition further.

    SWOT Analysis

    Strengths

    • High demand for regulatory compliance in the medical device industry.
    • Technological advancements improving testing accuracy and efficiency.
    • Established relationships with regulatory bodies enhancing credibility.
    • Diverse service offerings catering to various medical device categories.
    • Expertise in specialized testing methods and protocols.

    Weaknesses

    • High operational costs associated with advanced testing equipment.
    • Dependence on regulatory changes which can impact service demand.
    • Limited market presence in emerging economies.
    • Potential skill gaps in workforce for new testing technologies.
    • Long lead times for testing processes may deter clients.

    Opportunities

    • Growing global healthcare expenditure increasing demand for medical devices.
    • Expansion into emerging markets with rising healthcare needs.
    • Partnerships with device manufacturers for integrated testing solutions.
    • Increased focus on personalized medicine and innovative devices.
    • Adoption of digital technologies for remote testing and monitoring.

    Threats

    • Intense competition from established and new testing service providers.
    • Regulatory changes that may impose stricter testing requirements.
    • Economic downturns affecting healthcare budgets and spending.
    • Rapid technological changes requiring constant adaptation.
    • Cybersecurity risks associated with digital testing solutions.

    Summary

    The Medical Devices Testing Services Market is characterized by strong demand, driven by regulatory compliance and technological advancements. The market is also characterized by a high level of competition and high operational costs. Opportunities for growth lie in the development of emerging markets and in strategic alliances. Threats to growth lie in the threat of changing regulations and in the impact of economic fluctuations on the demand for testing services. Companies should use their strengths to take advantage of the opportunities and minimize the threats.

    Market Summary

    As per Market Research Future Analysis, the Medical Device Testing Services Market was valued at 10.15 USD Billion in 2024 and is projected to grow to 27.01 USD Billion by 2035, with a CAGR of approximately 9.30% from 2025 to 2034. The market is driven by stringent regulatory requirements, the increasing complexity of medical devices, and the need for risk mitigation. Key regulatory bodies, such as the FDA and EMA, enforce rigorous testing standards to ensure patient safety and device efficacy. The market is characterized by a growing trend towards global harmonization of regulations, necessitating consistent testing services across regions.

    Key Market Trends & Highlights

    The Medical Device Testing Services Market is influenced by several key trends.

    • Market Size in 2024: 10.15 USD Billion; Expected to reach 27.01 USD Billion by 2035. CAGR from 2025 to 2034: Approximately 9.30%; driven by stringent regulatory requirements. Microbiology & Sterility Tests segment holds 34.2% revenue share in 2022; critical for patient safety. Clinical phase dominates with over 68.8% revenue share in 2022; essential for regulatory approval.

    Market Size & Forecast

    2024 Market Size USD 10.15 Billion
    2035 Market Size USD 27.01 Billion
    CAGR (2025-2035) 9.30%
    Largest Regional Market Share in 2022 North America.

    Major Players

    <p>SGS S.A.; Labcorp (Toxikon, Inc); American Preclinical Services; Charles River Laboratories; Sterigenics International LLC; Eurofins Scientific; Intertek Group Plc.</p>

    Market Trends

    Stringent regulatory requirements and standards are driving the market growth.

    Market CAGR for medical device testing services is being driven by the rising stringent regulatory requirements and standards. Medical devices are subject to rigorous testing and quality assurance processes to make sure they are safe and effective for patient use. Advances in medical device technology leading to the development of increasingly complex devices, such as implantable devices, diagnostic equipment and digital health solutions. Comprehensive testing is essential to ensure the safety, reliability and performance of these complex devices.

    Regulatory bodies, like the US Food and the Drug Administration (FDA) in the US and European Medicine Agency (EMA) in Europe, mandate thorough testing to protect patient safety. As regulations evolve and become more stringent, manufacturers increasingly rely on testing services to meet compliance requirements. There is a growing trend toward the global harmonization of medical device regulations, like the International Medical Device Regulators Forum (IMDRF) and the Medical Device Single Audit Program (MDSAP). These initiatives encourage standardized testing and quality standards across different regions, driving the need for consistent testing services.

    Further, manufacturers and healthcare organizations seek to mitigate risks associated with medical devices, including recalls and adverse events. In order to bring medical devices to market, manufacturers must demonstrate compliance with regulatory requirements. Testing services provide the necessary evidence of safety and efficiency, facilitating market entry and regulatory approvals.

    High-quality testing services help manufacturers maintain their reputation and credibility by ensuring that their products meet the highest standards. Ongoing innovation in medical device technology necessitates continuous testing and validation of new features and capabilities. After a medical device is on the market, ongoing surveillance and testing are required to monitor its performance, detect issues and make improvements. Further, medical device manufacturers often expand their market presence internationally. This expansion requires compliance with various regional and national regulations, driving the need for testing services that can address diverse regulatory requirements.

    A growing focus on patient-centered healthcare emphasizes the importance of safe and effective medical devices. Rigorous testing ensures that devices meet the expectations of healthcare providers and patients. The primary objective of strict approval norms is to ensure the safety of the patients and users of medical devices. Additionally, adherence to strict approval norms helps minimize the likelihood of product recalls and legal liabilities for manufacturers. Thus driving the Medical Device Testing Services market revenue.

    <p>The increasing complexity of medical devices necessitates a robust testing framework to ensure safety and efficacy, reflecting a growing emphasis on regulatory compliance and patient outcomes.</p>

    U.S. Food and Drug Administration (FDA)

    Medical Device Testing Services Market Market Drivers

    Increasing Regulatory Compliance Requirements

    The Global Medical Device Testing Services Market Industry is experiencing heightened scrutiny from regulatory bodies, necessitating rigorous testing protocols. As governments worldwide implement stricter regulations to ensure patient safety and product efficacy, manufacturers are compelled to invest in comprehensive testing services. This trend is particularly evident in regions like North America and Europe, where compliance with standards such as ISO 13485 and FDA regulations is paramount. The growing emphasis on regulatory compliance is likely to drive the market's expansion, as companies seek to avoid costly recalls and legal repercussions, thereby contributing to the projected market value of 10.2 USD Billion in 2024.

    Market Segment Insights

    Medical Device Testing Services Service Insights

    <p>The Medical Device Testing Services Market segmentation, based on service, includes Biocompatibility Tests, Chemistry Tests and Microbiology test and sterility Tests. The microbiology &amp; sterility test segment dominates the market and accounts for 34.2% revenue share in 2022. The dominance of the category is due to their critical role in ensuring the safety and efficacy of medical devices. Regulatory bodies like the FDA and EMA require manufacturers to adhere to stringent microbiological and sterility testing standards. It has an essential role in patient safety, quality control and mitigation of risk and has a diverse application across diverse medical device categories.</p>

    <p>The second most popular service is biocompatibility testing, as it is an indispensable service that helps manufacturers assess the compatibility of their devices with the human body.</p>

    Medical Device Testing Services Phase Insights

    <p>The Medical Device Testing Services Market segmentation, based on phase, includes Preclinical and Clinical. The clinical category dominates the market, accounting for more than 68.8% of revenue in 2022. The regulatory bodies mandate extensive clinical testing for medical devices; in order to gain regulatory approval and market access, manufacturers are required to conduct clinical trials that assess the safety and the efficacy. The clinical phase provides patient safety assurance, efficacy validation, competitive advantage, innovation support, reimbursement and insurance coverage and long-term device performance.</p>

    <p>Further, the preclinical phase is expected to attain stable growth due to a growing number of companies investing in the R&amp;D of new medical devices for rare diseases.</p>

    <p>Figure 1: Medical Device Testing Services Market, by Phase, 2022 &amp; 2032 (USD Billion)</p>

    Get more detailed insights about Medical Device Testing Services Market Research Report 2035

    Regional Insights

    By region, the study gives market insights into the North America, Europe, Asia-Pacific and the Rest of the World. The North American Medical Device Testing Services market area dominates the market as the region has one of the most stringent and well-established regulatory environments for medical devices. There is a presence of a large medical industry and hub for medical device innovation and technological advancements in this region. North American region has an innovation culture, extensive clinical trial activity, market access opportunities, commitment to quality assurance, access to expertise and global reach of service providers.

    Further, the prime countries studied in the market report are The US, Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 2: MEDICAL DEVICE TESTING SERVICES MARKET SHARE BY REGION 2022 (USD Billion)MEDICAL DEVICE TESTING SERVICES MARKET SHARE BY REGION 2022

    Source: The Secondary Research, Primary Research, MRFR Database and Analyst Review

    Europe's Medical Device Testing Services market accounts for the second-largest market share as the region has a strong and well-established healthcare infrastructure with advanced hospitals, research centers and healthcare professionals. Further, the German Medical Device Testing Services market held largest market share, and the U.K. Medical Device Testing Services market was the fastest-growing market in the European region.

    The Asia-Pacific Medical Device Testing Services Market is expected to rise at the rapid CAGR from 2023 to 2032. This is due to expanding healthcare infrastructure, increasing medical device manufacturing and increased regulatory compliance. Moreover, China’s Medical Device Testing Services market held the largest market revenue, and the Indian Medical Device Testing Services market was the fastest-growing market in the Asia-Pacific region.

    Key Players and Competitive Insights

    Leading market participants are investing hugely in research and development in order to spread their product lines, which will help the Medical Device Testing Services market grow even more. Market players are also undertaking a variety of strategic activities to spread their global footprint, with important market developments including contractual agreements, new product launches, mergers and acquisitions, higher investments, and collaboration with other organizations. To spread and survive in a more competitive and rising market climate, the Medical Device Testing Services industry must offer cost-effective items.

    Manufacturing locally to minimize the operational costs is one of the key business tactics used by the manufacturers in the global Medical Device Testing Services industry to benefit the clients and increase the market sector. In recent years, the Medical Device Testing Services industry has provided some of the most significant advantages to the healthcare industry.

    Major participants in the Medical Device Testing Services market, including SGS S.A.; Labcorp (Toxikon, Inc); American Preclinical Services; Charles River Laboratories; Sterigenics International LLC; Element Minnetonka; North America Science Associates Inc.; Eurofins Scientific; Pace Analytical Services LLC; Intertek Group Plc, and others, are attempting to increase the market demand by investing in the research and development operations.

    Charles River Laboratories International Inc. is a company that provides a broader range of products and services to support the pharmaceutical, biotechnology and healthcare industries in their research and drug development efforts. Founded in 1947, the company provides a wide range of preclinical research services, including in vivo studies, pharmacology, toxicology and efficacy testing. The company specializes in safety assessment services, which involve assessing the potential risks and safety profiles of new drugs and therapies.

    In February 2022, Charles River Laboratories, a leading provider of preclinical research services, announced a partnership with Kibur Medical, a leading provider of implantable microdevice technology. The partnership will enable Charles River Laboratories to offer its clients access to Kibur Medical’s IMD technology for preclinical in-vivo oncology studies.

    LabCorp, a leading life sciences company that specializes in diagnostic testing, drug development and clinical trial services. Headquartered in Burlington, North Carolina, LabCorp plays a crucial role in healthcare by providing a wide range of laboratory testing and diagnostic services to patients, healthcare providers, pharmaceutical companies and researchers. In November 2021, LabCorp, a leading provider of clinical laboratory services, announced the acquisition of Toxikon, a leading provider of nonclinical toxicology testing services for medical devices and pharmaceuticals. The acquisition will enable LabCorp to expand its portfolio of medical device testing services to strengthen its position in the preclinical testing market.

    Key Companies in the Medical Device Testing Services Market market include

    Industry Developments

    • Q2 2024: Eurofins Medical Device Testing Expands Capabilities with New Laboratory in Singapore Eurofins Medical Device Testing announced the opening of a new laboratory in Singapore to expand its testing capabilities and support medical device manufacturers in the Asia-Pacific region.
    • Q2 2024: Nelson Labs Announces Acquisition of Gibraltar Laboratories Nelson Labs, a leading provider of microbiological and analytical chemistry testing for medical devices, acquired Gibraltar Laboratories to enhance its service offerings and geographic reach.
    • Q1 2024: FDA Authorizes New Sterility Testing Protocol for Medical Device Manufacturers The FDA approved a new sterility testing protocol, allowing medical device manufacturers to utilize advanced rapid microbiological methods for regulatory submissions.
    • Q2 2024: SGS Opens New Medical Device Testing Laboratory in Shanghai SGS, a global testing and certification company, opened a new medical device testing laboratory in Shanghai to meet growing demand for regulatory compliance services in China.
    • Q1 2024: Intertek Launches Biocompatibility Testing Services for Wearable Medical Devices Intertek announced the launch of specialized biocompatibility testing services tailored for wearable medical devices, addressing the increasing complexity of device materials.
    • Q2 2024: Element Materials Technology Acquires Nanosafe Inc. Element Materials Technology acquired Nanosafe Inc., a provider of nanotechnology-focused medical device testing, to expand its portfolio in advanced device safety evaluation.
    • Q1 2024: TÜV SÜD Appoints New CEO for Global Medical Device Testing Division TÜV SÜD announced the appointment of a new CEO to lead its global medical device testing division, aiming to drive innovation and growth in regulatory testing services.
    • Q2 2024: Medistri Secures ISO 17025 Accreditation for Expanded Medical Device Testing Services Medistri received ISO 17025 accreditation for its expanded medical device testing services, strengthening its position as a certified provider for device manufacturers.
    • Q1 2024: WuXi AppTec Medical Device Testing Announces Strategic Partnership with Medtronic WuXi AppTec Medical Device Testing entered a strategic partnership with Medtronic to provide comprehensive testing services for Medtronic’s next-generation implantable devices.
    • Q2 2024: Pace Analytical Launches New Extractables and Leachables Testing Service for Medical Devices Pace Analytical introduced a new extractables and leachables testing service to help medical device manufacturers comply with evolving regulatory requirements.
    • Q1 2024: Eurofins Medical Device Testing Receives FDA Approval for New Biocompatibility Testing Method Eurofins Medical Device Testing received FDA approval for a novel biocompatibility testing method, enabling faster and more accurate safety assessments for device manufacturers.
    • Q2 2024: SGS Acquires LabCorp’s Medical Device Testing Division SGS completed the acquisition of LabCorp’s medical device testing division, expanding its global footprint and service capabilities in regulatory testing.

    Future Outlook

    Medical Device Testing Services Market Future Outlook

    <p>The Medical Device Testing Services Market is poised for growth at a 9.30% CAGR from 2025 to 2035, driven by technological advancements, regulatory changes, and increasing demand for innovative medical devices.</p>

    New opportunities lie in:

    • <p>Invest in AI-driven testing technologies to enhance efficiency and accuracy. Expand service offerings to include biocompatibility testing for emerging materials. Develop strategic partnerships with startups to innovate testing methodologies.</p>

    <p>By 2035, the market is expected to exhibit robust growth, reflecting evolving industry standards and consumer demands.</p>

    Market Segmentation

    Medical Device Testing Services Phase Outlook

    • Preclinical
    • Clinical

    Medical Device Testing Services Service Outlook

    • Biocompatibility Tests
    • Chemistry Test
    • Microbiology & Sterility Test

    Medical Device Testing Services Regional Outlook

    • {""=>["US"
    • "Canada"]}
    • {""=>["Germany"
    • "France"
    • "UK"
    • "Italy"
    • "Spain"
    • "Rest of Europe"]}
    • {""=>["China"
    • "Japan"
    • "India"
    • "Australia"
    • "South Korea"
    • "Rest of Asia-Pacific"]}
    • {""=>["Middle East"
    • "Africa"
    • "Latin America"]}

    Report Scope

    Report Attribute/MetricDetails
    Market Size 2024  10.15 (USD Billion)
    Market Size 2025  11.10 (USD Billion)
    Market Size 203527.01 (USD Billion)
    Compound Annual Growth Rate (CAGR)9.30% (2025 - 2035)
    Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year2024
    Market Forecast Period2025 - 2035
    Historical Data2020 - 2024
    Report CoverageRevenue Forecast, The Market Competitive Landscape, Growth Factors, and Trends
    Segments CoveredService, Phase and Region
    Geographies CoveredNorth America, Europe, Asia Pacific, and the Rest of the World
    Countries CoveredThe US, Canada, Germany, France, UK, Italy, Spain, Japan, China, India, Australia, South Korea, and Brazil
    Key Companies ProfiledSGS S.A.; Labcorp (Toxikon, Inc); American Preclinical Services; Sterigenics International LLC; Charles River Laboratories; Element Minnetonka; North America Science Associates Inc.; Eurofins Scientific; Pace Analytical Services LLC; Intertek Group Plc.
    Key Market Opportunities·         Growing complexity of devices and the need for risk mitigation.
    Key Market Dynamics·         Stringent regulatory requirements and standards imposed on medical device manufacturers.

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What is the projected growth of the Medical Device Testing Services market?

    The Medical Device Testing Services market is the expected increase in total market value of 27.01 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Medical Device Testing Services market?

    Medical Device Testing Services market size was valued at approximately 10.15 billion USD in 2024. This figure will reach 27.01 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Medical Device Testing Services market?

    Medical Device Testing Services market is expected to grow at a CAGR of 9.3% between 2025 and 2035.

    How much will the Medical Device Testing Services market be worth by 2035?

    Medical Device Testing Services market is expected to be worth of 27.01 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Medical Device Testing Services market perform over the next 10 years?

    Over the next 10 years the Medical Device Testing Services market is expected to shift from usd billion 10.15 to 27.01 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    How much is the Medical Device Testing Services market?

    The Medical Device Testing Services Market size valued at USD 8.5 Billion in 2024.

    1. Table of Contents
    2. Executive Summary
    3. Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    4. Research Methodology
      1. Overview
      2. Data Mining
      3. Secondary Research
      4. Primary Research
        1. Primary Interviews and Information Gathering Process
        2. Breakdown of Primary Respondents
      5. Forecasting Model
      6. Market Size Estimation
        1. Bottom-up Approach
        2. Top-Down Approach
      7. Data Triangulation
      8. Validation
    5. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    6. MARKET FACTOR ANALYSIS
      1. Value Chain Analysis
      2. Porter’s Five Forces Analysis
        1. Bargaining Power of Suppliers
        2. Bargaining Power of Buyers
        3. Threat of New Entrants
        4. Threat of Substitutes
        5. Intensity of Rivalry
      3. COVID-19 Impact Analysis
        1. Market Impact Analysis
        2. Regional Impact
        3. Opportunity and Threat Analysis
    7. GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE
      1. Overview
      2. Biocompatibility Tests
      3. Chemistry Test
      4. Microbiology & Sterility Test
    8. GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE
      1. Overview
      2. Preclinical
      3. Clinical
    9. GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, BY REGION
      1. Overview
      2. North America
        1. US
        2. Canada
      3. Europe
        1. Germany
        2. France
        3. UK
        4. Italy
        5. Spain
        6. Rest of Europe
      4. Asia-Pacific
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Australia
        6. Rest of Asia-Pacific
      5. Rest of the World
        1. Middle East
        2. Africa
        3. Latin America
    10. Competitive Landscape
      1. Overview
      2. Competitive Analysis
      3. Market Share Analysis
      4. Major Growth Strategy in the Global Medical Device Testing Services Market,
      5. Competitive Benchmarking
      6. Leading Players in Terms of Number of Developments in the Global Medical Device Testing Services Market,
      7. Key developments and Growth Strategies
        1. New Product Launch/Service Deployment
        2. Merger & Acquisitions
        3. Joint Ventures
      8. Major Players Financial Matrix
        1. Sales & Operating Income, 2022
        2. Major Players R&D Expenditure. 2022
    11. COMPANY PROFILES
      1. SGS SA
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      2. Labcorp
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      3. American Preclinical Services
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      4. Sterigenics International LLC
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      5. Charles River Laboratories
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      6. Element Minnetonka
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      7. North America Science Associates Inc
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      8. Eurofins Scientific
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      9. Pace Analytical Services LLC
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      10. Intertek Group Plc
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
    12. APPENDIX
      1. References
      2. Related Reports
    13. List of Tables and Figures
      1. LIST OF TABLES
      2. TABLE 1 GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, SYNOPSIS, 2018-2034
      3. TABLE 2 GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, ESTIMATES & FORECAST, 2018-2034 (USD BILLION)
      4. TABLE 3 GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      5. TABLE 4 GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      6. TABLE 5 NORTH AMERICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      7. TABLE 6 NORTH AMERICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      8. TABLE 7 US: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      9. TABLE 8 US: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      10. TABLE 9 CANADA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      11. TABLE 10 CANADA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      12. TABLE 1 EUROPE: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      13. TABLE 2 EUROPE: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      14. TABLE 3 GERMANY: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      15. TABLE 4 GERMANY: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      16. TABLE 5 FRANCE: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      17. TABLE 6 FRANCE: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      18. TABLE 7 ITALY: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      19. TABLE 8 ITALY: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      20. TABLE 9 SPAIN: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      21. TABLE 10 SPAIN: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      22. TABLE 11 UK: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      23. TABLE 12 UK: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      24. TABLE 13 REST OF EUROPE: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      25. TABLE 14 REST OF EUROPE: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      26. TABLE 15 ASIA-PACIFIC: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      27. TABLE 16 ASIA-PACIFIC: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      28. TABLE 17 JAPAN: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      29. TABLE 18 JAPAN: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      30. TABLE 19 CHINA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      31. TABLE 20 CHINA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      32. TABLE 21 INDIA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      33. TABLE 22 INDIA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      34. TABLE 23 AUSTRALIA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      35. TABLE 24 AUSTRALIA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      36. TABLE 25 SOUTH KOREA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      37. TABLE 26 SOUTH KOREA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      38. TABLE 27 REST OF ASIA-PACIFIC: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      39. TABLE 28 REST OF ASIA-PACIFIC: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      40. TABLE 29 REST OF THE WORLD: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      41. TABLE 30 REST OF THE WORLD: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      42. TABLE 31 MIDDLE EAST: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      43. TABLE 32 MIDDLE EAST: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      44. TABLE 33 AFRICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      45. TABLE 34 AFRICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
      46. TABLE 35 LATIN AMERICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
      47. TABLE 36 LATIN AMERICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION) LIST OF FIGURES
      48. FIGURE 1 RESEARCH PROCESS
      49. FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET
      50. FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET
      51. FIGURE 4 GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY SERVICE, 2022
      52. FIGURE 5 GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY PHASE, 2022
      53. FIGURE 6 GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY REGION, 2022
      54. FIGURE 7 NORTH AMERICA: MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY REGION, 2022
      55. FIGURE 8 EUROPE: MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY REGION, 2022
      56. FIGURE 9 ASIA-PACIFIC: MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY REGION, 2022
      57. FIGURE 10 REST OF THE WORLD: MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY REGION, 2022
      58. FIGURE 11 GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
      59. FIGURE 12 SGS SA: FINANCIAL OVERVIEW SNAPSHOT
      60. FIGURE 13 SGS SA: SWOT ANALYSIS
      61. FIGURE 14 LABCORP: FINANCIAL OVERVIEW SNAPSHOT
      62. FIGURE 15 LABCORP: SWOT ANALYSIS
      63. FIGURE 16 AMERICAN PRECLINICAL SERVICES: FINANCIAL OVERVIEW SNAPSHOT
      64. FIGURE 17 AMERICAN PRECLINICAL SERVICES: SWOT ANALYSIS
      65. FIGURE 18 STERIGENICS INTERNATIONAL LLC: FINANCIAL OVERVIEW SNAPSHOT
      66. FIGURE 19 STERIGENICS INTERNATIONAL LLC: SWOT ANALYSIS
      67. FIGURE 20 CHARLES RIVER LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
      68. FIGURE 21 CHARLES RIVER LABORATORIES: SWOT ANALYSIS
      69. FIGURE 22 ELEMENT MINNETONKA: FINANCIAL OVERVIEW SNAPSHOT
      70. FIGURE 23 ELEMENT MINNETONKA: SWOT ANALYSIS
      71. FIGURE 24 NORTH AMERICA SCIENCE ASSOCIATES INC: FINANCIAL OVERVIEW SNAPSHOT
      72. FIGURE 25 NORTH AMERICA SCIENCE ASSOCIATES INC: SWOT ANALYSIS
      73. FIGURE 26 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT
      74. FIGURE 27 EUROFINS SCIENTIFIC: SWOT ANALYSIS
      75. FIGURE 28 PACE ANALYTICAL SERVICES LLC: FINANCIAL OVERVIEW SNAPSHOT
      76. FIGURE 29 PACE ANALYTICAL SERVICES LLC: SWOT ANALYSIS
      77. FIGURE 30 INTERTEK GROUP PLC: FINANCIAL OVERVIEW SNAPSHOT
      78. FIGURE 31 INTERTEK GROUP PLC: SWOT ANALYSIS

    Market Segmentation Tab

    Medical Device Testing Services Service Outlook (USD Billion, 2018-2034)

    • Biocompatibility Tests
    • Chemistry Test
    • Microbiology & Sterility Test

    Medical Device Testing Services Phase Outlook (USD Billion, 2018-2034)

    • Preclinical
    • Clinical

    Medical Device Testing Services Regional Outlook (USD Billion, 2018-2034)

    • North America Outlook (USD Billion, 2018-2034)
      • North America Medical Device Testing Services by Service
        • Biocompatibility Tests
        • Chemistry Test
        • Microbiology & Sterility Test
      • North America Medical Device Testing Services by Phase
        • Preclinical
        • Clinical
      • US Outlook (USD Billion, 2018-2034)
      • US Medical Device Testing Services by Service
        • Biocompatibility Tests
        • Chemistry Test
        • Microbiology & Sterility Test
      • US Medical Device Testing Services by Phase
        • Preclinical
        • Clinical
      • CANADA Outlook (USD Billion, 2018-2034)
      • CANADA Medical Device Testing Services by Service
        • Biocompatibility Tests
        • Chemistry Test
        • Microbiology & Sterility Test
      • CANADA Medical Device Testing Services by Phase
        • Preclinical
        • Clinical
      • Europe Outlook (USD Billion, 2018-2034)
        • Europe Medical Device Testing Services by Service
          • Biocompatibility Tests
          • Chemistry Test
          • Microbiology & Sterility Test
        • Europe Medical Device Testing Services by Phase
          • Preclinical
          • Clinical
        • Germany Outlook (USD Billion, 2018-2034)
        • Germany Medical Device Testing Services by Service
          • Biocompatibility Tests
          • Chemistry Test
          • Microbiology & Sterility Test
        • Germany Medical Device Testing Services by Phase
          • Preclinical
          • Clinical
        • France Outlook (USD Billion, 2018-2034)
        • France Medical Device Testing Services by Service
          • Biocompatibility Tests
          • Chemistry Test
          • Microbiology & Sterility Test
        • France Medical Device Testing Services by Phase
          • Preclinical
          • Clinical
        • UK Outlook (USD Billion, 2018-2034)
        • UK Medical Device Testing Services by Service
          • Biocompatibility Tests
          • Chemistry Test
          • Microbiology & Sterility Test
        • UK Medical Device Testing Services by Phase
          • Preclinical
          • Clinical
        • ITALY Outlook (USD Billion, 2018-2034)
        • ITALY Medical Device Testing Services by Service
          • Biocompatibility Tests
          • Chemistry Test
          • Microbiology & Sterility Test
        • ITALY Medical Device Testing Services by Phase
          • Preclinical
          • Clinical
        • SPAIN Outlook (USD Billion, 2018-2034)
        • Spain Medical Device Testing Services by Service
          • Biocompatibility Tests
          • Chemistry Test
          • Microbiology & Sterility Test
        • Spain Medical Device Testing Services by Phase
          • Preclinical
          • Clinical
        • Rest Of Europe Outlook (USD Billion, 2018-2034)
        • Rest Of Europe Medical Device Testing Services by Service
          • Biocompatibility Tests
          • Chemistry Test
          • Microbiology & Sterility Test
        • REST OF EUROPE Medical Device Testing Services by Phase
          • Preclinical
          • Clinical
        • Asia-Pacific Outlook (USD Billion, 2018-2034)
          • Asia-Pacific Medical Device Testing Services by Service
            • Biocompatibility Tests
            • Chemistry Test
            • Microbiology & Sterility Test
          • Asia-Pacific Medical Device Testing Services by Phase
            • Preclinical
            • Clinical
          • China Outlook (USD Billion, 2018-2034)
          • China Medical Device Testing Services by Service
            • Biocompatibility Tests
            • Chemistry Test
            • Microbiology & Sterility Test
          • China Medical Device Testing Services by Phase
            • Preclinical
            • Clinical
          • Japan Outlook (USD Billion, 2018-2034)
          • Japan Medical Device Testing Services by Service
            • Biocompatibility Tests
            • Chemistry Test
            • Microbiology & Sterility Test
          • Japan Medical Device Testing Services by Phase
            • Preclinical
            • Clinical
          • India Outlook (USD Billion, 2018-2034)
          • India Medical Device Testing Services by Service
            • Biocompatibility Tests
            • Chemistry Test
            • Microbiology & Sterility Test
          • India Medical Device Testing Services by Phase
            • Preclinical
            • Clinical
          • Australia Outlook (USD Billion, 2018-2034)
          • Australia Medical Device Testing Services by Service
            • Biocompatibility Tests
            • Chemistry Test
            • Microbiology & Sterility Test
          • Australia Medical Device Testing Services by Phase
            • Preclinical
            • Clinical
          • Rest of Asia-Pacific Outlook (USD Billion, 2018-2034)
          • Rest of Asia-Pacific Medical Device Testing Services by Service
            • Biocompatibility Tests
            • Chemistry Test
            • Microbiology & Sterility Test
          • Rest of Asia-Pacific Medical Device Testing Services by Phase
            • Preclinical
            • Clinical
          • Rest of the World Outlook (USD Billion, 2018-2034)
            • Rest of the World Medical Device Testing Services by Service
              • Biocompatibility Tests
              • Chemistry Test
              • Microbiology & Sterility Test
            • Rest of the World Medical Device Testing Services by Phase
              • Preclinical
              • Clinical
            • Middle East Outlook (USD Billion, 2018-2034)
            • Middle East Medical Device Testing Services by Service
              • Biocompatibility Tests
              • Chemistry Test
              • Microbiology & Sterility Test
            • Middle East Medical Device Testing Services by Phase
              • Preclinical
              • Clinical
            • Africa Outlook (USD Billion, 2018-2034)
            • Africa Medical Device Testing Services by Service
              • Biocompatibility Tests
              • Chemistry Test
              • Microbiology & Sterility Test
            • Africa Medical Device Testing Services by Phase
              • Preclinical
              • Clinical
            • Latin America Outlook (USD Billion, 2018-2034)
            • Latin America Medical Device Testing Services by Service
              • Biocompatibility Tests
              • Chemistry Test
              • Microbiology & Sterility Test
            • Latin America Medical Device Testing Services by Phase
              • Preclinical
              • Clinical
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials